You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

WT1

Showing 1 - 25 of 2,180
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Day +60 WT1 Assessment on Bone Marrow in Predicting Relapse and

Completed
  • Assessment of the WT1 Expression Level on Bone Marrow Samples Collected at Day +60 After Allogeneic Stem
    • Roma, Italy
      Servizio E Dh Di Ematologia
    Feb 23, 2023

    Esophageal Cancer, Pancreas Cancer, Ovarian Cancer Trial in Edegem (IL15-transpresenting WT1-targeted Dendritic Cell Vaccine)

    Not yet recruiting
    • Esophageal Cancer
    • +3 more
    • IL15-transpresenting WT1-targeted Dendritic Cell Vaccine
    • Edegem, Belgium
      Antwerp University Hospital
    Jul 19, 2023

    Malignant Pleural Mesothelioma Trial in Edegem, Ghent, Sint-Niklaas (Dendritic cell vaccination, Atezolizumab,

    Not yet recruiting
    • Malignant Pleural Mesothelioma
    • Dendritic cell vaccination
    • +2 more
    • Edegem, Antwerp, Belgium
    • +2 more
    Feb 28, 2023

    Multiple Myeloma Trial in New York (drug, biological, procedure)

    Active, not recruiting
    • Multiple Myeloma
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Jan 3, 2023

    Colorectal Cancer, Gastric Cancer, Pancreatic Cancer Trial in Huntersville, Canton (CUE-102)

    Recruiting
    • Colorectal Cancer
    • +3 more
    • Huntersville, North Carolina
    • +1 more
    Jul 5, 2022

    Multiple Myeloma Trial in New York (CT7, MAGE-A3, and WT1 mRNA-electroporated Langerhans cells ( LCs), Standard of care)

    Completed
    • Multiple Myeloma
    • CT7, MAGE-A3, and WT1 mRNA-electroporated Langerhans cells ( LCs)
    • Standard of care
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Jun 22, 2022

    Advanced Malignancies, Advanced Cancer Trial in United States (ASP7517, Pembrolizumab)

    Recruiting
    • Advanced Malignancies
    • Advanced Cancer
    • Atlanta, Georgia
    • +3 more
    Aug 2, 2022

    Mesothelioma, Pleural Mesothelioma, Wilms Tumor Trial in United States (Galinpepimut-S, Nivolumab, Sargramostim)

    Active, not recruiting
    • Mesothelioma
    • +2 more
    • Galinpepimut-S
    • +2 more
    • Basking Ridge, New Jersey
    • +5 more
    Nov 23, 2022

    Acute Myeloid Leukemia, EBV-Positive Neoplastic Cells Present, HLA-A*0201 Positive Cells Present Trial in Seattle (Aldesleukin,

    Terminated
    Has Results
    • Acute Myeloid Leukemia
    • +4 more
    • Aldesleukin
    • +2 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Oct 15, 2021

    Leukemia, Myelodysplastic Syndrome Trial in New York (WT1-sensitized T cells)

    Completed
    • Leukemia
    • Myelodysplastic Syndrome
    • WT1-sensitized T cells
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Mar 1, 2021

    Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML) Trial run by the NHLBI

    Completed
    Has Results
    • Myelodysplastic Syndrome (MDS)
    • +2 more
    • WT1:126-134
    • +3 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Jun 15, 2021

    Advanced Pleural Malignant Mesothelioma, HLA-A*0201 Positive Cells Present, Recurrent Non-Small Cell Lung Carcinoma Trial in

    Terminated
    Has Results
    • Advanced Pleural Malignant Mesothelioma
    • +10 more
    • Aldesleukin
    • +4 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Aug 16, 2021

    Acute Myeloid Leukemia Trial in Beijing (DC vaccine)

    Recruiting
    • Acute Myeloid Leukemia
    • DC vaccine
    • Beijing, Beijing, China
      Department of hematology
    Aug 16, 2021

    Colonic Tumors Trial in Wuhan (neoadjuvant chemo)

    Recruiting
    • Colonic Neoplasms
    • neoadjuvant chemotherapy
    • Wuhan, Hubei, China
      Tongji Hospital, Huazhong University of Science and Technology
    Jul 19, 2022

    Tumors, Breast Trial in Worldwide (GSK Biologicals' recombinant WT1 Antigen-Specific Cancer Immunotherapeutic (ASCI)

    Terminated
    Has Results
    • Neoplasms, Breast
    • GSK Biologicals' recombinant WT1 Antigen-Specific Cancer Immunotherapeutic (ASCI) GSK2302024A
    • +10 more
    • Newark, Delaware
    • +35 more
    Apr 30, 2021

    Ataxia, Spinocerebellar, Insulin-Like Growth Factor I, Medicine, Chinese Traditional Trial in Changhua (Chinese medicine WT)

    Recruiting
    • Ataxia, Spinocerebellar
    • +2 more
    • Chinese medicine WT
    • Changhua, Taiwan
      Changhua Christian Hospital
    Oct 22, 2021

    Breast Cancer Trial (WT_vDIBH, VMAT_FB)

    Completed
    • Breast Cancer
    • WT_vDIBH
    • VMAT_FB
    • (no location specified)
    Apr 12, 2022

    SARS-CoV-2 Infection, COVID-19 Trial in United States (BNT162b5 Bivalent (WT/OMI BA.2), BNT162b2 Bivalent (WT/OMI BA.1))

    Recruiting
    • SARS-CoV-2 Infection
    • COVID-19
    • BNT162b5 Bivalent (WT/OMI BA.2)
    • BNT162b2 Bivalent (WT/OMI BA.1)
    • Anaheim, California
    • +9 more
    Aug 8, 2022

    Leukemia, Acute Lymphocytic (ALL), Leukemia, Acute Myelogenous (AML), MDS Trial in Guangzhou (Chimeric antigen receptor T cells,

    Recruiting
    • Leukemia, Acute Lymphocytic (ALL)
    • +2 more
    • Chimeric antigen receptor T cells
    • peptide specific dendritic cell
    • Guangzhou, Guangdong, China
      Zhujiang Hospital, Southern Medical University
    Aug 1, 2021

    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer Trial in New York (biological, drug, other)

    Completed
    • Fallopian Tube Cancer
    • +2 more
    • filgrastim
    • +3 more
    • New York, New York
      Memorial Sloan-Kettering Cancer Center
    Aug 5, 2021

    Acute Myeloid Leukemia Trial in Nashville (Biopsy of Bone, Cytarabine, Daunorubicin)

    Recruiting
    • Acute Myeloid Leukemia
    • Biospecimen Collection
    • +5 more
    • Buffalo, New York
    • +1 more
    Jan 27, 2023

    MDS, Acute Myeloid Leukemia Trial in Campinas (Autologous dendritic cells electroporated with WT1 mRNA)

    Active, not recruiting
    • Myelodysplastic Syndromes
    • Acute Myeloid Leukemia
    • Autologous dendritic cells electroporated with WT1 mRNA
    • Campinas, São Paulo, Brazil
      Hematology and Transfusion Medicine Center
    Oct 9, 2020

    HIV Trial in United States (BMS-936559, Placebo for BMS-936559)

    Completed
    • HIV Infections
    • Aurora, Colorado
    • +4 more
    Nov 4, 2021

    Multiple Myeloma, Minimal Residual Disease, High-Risk Cancer Trial in New York (WT1 Analog Peptide Vaccine, Sargramostim

    Unknown status
    • Multiple Myeloma
    • +2 more
    • WT1 Analog Peptide Vaccine
    • +2 more
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Jan 6, 2020

    Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS) Trial in United States (Infusion of NEXI-001 T Cells)

    Recruiting
    • Acute Myeloid Leukemia (AML)
    • Myelodysplastic Syndrome (MDS)
    • Infusion of NEXI-001 T Cells
    • Duarte, California
    • +4 more
    Feb 16, 2021